2024-12-30
2025-03-30
0000200406
country:US
jnj:TALVEYMember
jnj:InnovativeMedicineMember
jnj:OncologyMember
2024-01-01
2024-03-31
0000200406
us-gaap:NonUsMember
jnj:TALVEYMember
jnj:InnovativeMedicineMember
jnj:OncologyMember
2024-12-30
2025-03-30
0000200406
us-gaap:NonUsMember
jnj:TALVEYMember
jnj:InnovativeMedicineMember
jnj:OncologyMember
2024-01-01
2024-03-31
0000200406
jnj:TALVEYMember
jnj:InnovativeMedicineMember
jnj:OncologyMember
2024-12-30
2025-03-30
0000200406
jnj:TALVEYMember
jnj:InnovativeMedicineMember
jnj:OncologyMember
2024-01-01
2024-03-31
0000200406
country:US
jnj:TecvayliMember
jnj:InnovativeMedicineMember
jnj:OncologyMember
2024-12-30
2025-03-30
0000200406
country:US
jnj:TecvayliMember
jnj:InnovativeMedicineMember
jnj:OncologyMember
2024-01-01
2024-03-31
0000200406
us-gaap:NonUsMember
jnj:TecvayliMember
jnj:InnovativeMedicineMember
jnj:OncologyMember
2024-12-30
2025-03-30
0000200406
us-gaap:NonUsMember
jnj:TecvayliMember
jnj:InnovativeMedicineMember
jnj:OncologyMember
2024-01-01
2024-03-31
0000200406
jnj:TecvayliMember
jnj:InnovativeMedicineMember
jnj:OncologyMember
2024-12-30
2025-03-30
0000200406
jnj:TecvayliMember
jnj:InnovativeMedicineMember
jnj:OncologyMember
2024-01-01
2024-03-31
0000200406
country:US
jnj:ZYTIGAMember
jnj:InnovativeMedicineMember
jnj:OncologyMember
2024-12-30
2025-03-30
0000200406
country:US
jnj:ZYTIGAMember
jnj:InnovativeMedicineMember
jnj:OncologyMember
2024-01-01
2024-03-31
0000200406
us-gaap:NonUsMember
jnj:ZYTIGAMember
jnj:InnovativeMedicineMember
jnj:OncologyMember
2024-12-30
2025-03-30
0000200406
us-gaap:NonUsMember
jnj:ZYTIGAMember
jnj:InnovativeMedicineMember
jnj:OncologyMember
2024-01-01
2024-03-31
0000200406
jnj:ZYTIGAMember
jnj:InnovativeMedicineMember
jnj:OncologyMember
2024-12-30
2025-03-30
0000200406
jnj:ZYTIGAMember
jnj:InnovativeMedicineMember
jnj:OncologyMember
2024-01-01
2024-03-31
0000200406
country:US
jnj:OtherOncologyMember
jnj:InnovativeMedicineMember
jnj:OncologyMember
2024-12-30
2025-03-30
0000200406
country:US
jnj:OtherOncologyMember
jnj:InnovativeMedicineMember
jnj:OncologyMember
2024-01-01
2024-03-31
0000200406
us-gaap:NonUsMember
jnj:OtherOncologyMember
jnj:InnovativeMedicineMember
jnj:OncologyMember
2024-12-30
2025-03-30
0000200406
us-gaap:NonUsMember
jnj:OtherOncologyMember
jnj:InnovativeMedicineMember
jnj:OncologyMember
2024-01-01
2024-03-31
0000200406
jnj:OtherOncologyMember
jnj:InnovativeMedicineMember
jnj:OncologyMember
2024-12-30
2025-03-30
0000200406
jnj:OtherOncologyMember
jnj:InnovativeMedicineMember
jnj:OncologyMember
2024-01-01
2024-03-31
0000200406
country:US
jnj:InnovativeMedicineMember
jnj:ImmunologyMember
2024-12-30
2025-03-30
0000200406
country:US
jnj:InnovativeMedicineMember
jnj:ImmunologyMember
2024-01-01
2024-03-31
0000200406
us-gaap:NonUsMember
jnj:InnovativeMedicineMember
jnj:ImmunologyMember
2024-12-30
2025-03-30
0000200406
us-gaap:NonUsMember
jnj:InnovativeMedicineMember
jnj:ImmunologyMember
2024-01-01
2024-03-31
0000200406
jnj:InnovativeMedicineMember